These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 950957

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B, Stalder GA, Gudat F, Bianchi L, Froesner GG.
    Schweiz Med Wochenschr; 1982 Apr 12; 112(15):523-4. PubMed ID: 7079688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
    Stancek D, Fuchsberger N, Borecký L, Kotuliaková M, Hrúzik J, Sylvanová E, Sudová J.
    Acta Virol; 1988 Mar 12; 32(2):148-52. PubMed ID: 2899961
    [Abstract] [Full Text] [Related]

  • 6. [Markers of type B viral hepatitis].
    Brunello F, Emanuelli G, Camussi G.
    Minerva Med; 1979 Sep 26; 70(41):2791-800. PubMed ID: 386166
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapy for hepatitis B virus infection.
    Perrillo RP, Mason AL.
    Gastroenterol Clin North Am; 1994 Sep 26; 23(3):581-601. PubMed ID: 7527374
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H, Ayola B, Lok AS.
    Hepatology; 1996 Jul 26; 24(1):32-7. PubMed ID: 8707278
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
    Zhang X, Zoulim F, Habersetzer F, Xiong S, Trépo C.
    J Med Virol; 1996 Jan 26; 48(1):8-16. PubMed ID: 8825704
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
    Ruiz-Moreno M, Rúa MJ, Moraleda G, Guardia L, Moreno A, Carreño V.
    Pediatrics; 1992 Aug 26; 90(2 Pt 1):254-8. PubMed ID: 1641292
    [Abstract] [Full Text] [Related]

  • 17. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G, Santantonio T, Monno L, Milella M, Luchena N, Angarano G.
    Hepatogastroenterology; 1988 Apr 26; 35(2):57-61. PubMed ID: 3371847
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of a low dosage of human leukocyte interferon on chronic hepatitis B virus infection.
    Matsumura N, Yoshikawa T, Kondo M, Kawakami H, Kishida T.
    Digestion; 1983 Apr 26; 26(4):205-12. PubMed ID: 6873506
    [Abstract] [Full Text] [Related]

  • 19. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May 26; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of alpha interferon for the treatment of chronic hepatitis B infection in Christchurch.
    Burt MJ, Ross AG, Schroeder BA, Chambers ST, Chapman BA.
    N Z Med J; 1996 May 10; 109(1021):162-4. PubMed ID: 8657367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.